secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alto Neuroscience, Inc. (ANRO)
CIK:        0001999480
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001193125-25-019318
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alto Neuroscience enters $75M ATM equity offering; reports ~$168M cash as of Dec 31, 2024
--------------------------------------------------------------------------------

- Entered into sales agreement with Leerink Partners for at-the-market offering of up to $75M in common stock.
- Agent will receive up to 3.0% commission on shares sold; Company has no obligation to sell.
- Preliminary cash and cash equivalents of ~$168M as of Dec 31, 2024; final year-end results may differ materially.
- Registration statement on Form S-3 filed concurrently; ATM offering subject to SEC effectiveness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1999480/000119312525019318/0001193125-25-019318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1999480/000119312525019318/d843857d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-019318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer